CVRx vs Heartflow
CVRX and HTFL side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CVRX and HTFL compare
Heartflow is the larger company, worth 251 times as much as CVRx ($4.1B against $16.3M).
Heartflow grew revenue faster over the last twelve months (42.8% versus 12.0% for CVRx).
Heartflow keeps more of each dollar of sales as profit, with a net margin of −55.8% compared with −84.9% at CVRx.
CVRx scores higher on the StockData Score (8 against 5 for Heartflow), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CVRX | HTFL |
|---|---|---|
| Size and price | ||
| Market cap | $16.3M | $4.1B |
| Share price | $0.611 | $47.07 |
| Change, 1 year | −93.4% | 68.2% |
| Change, 5 years | −95.3% | – |
| Beta (5Y) | −0.96 | 1.48 |
| Employees | 223 | 843 |
| StockData Score | ||
| Total score | 8 (better) | 5 |
| Valuation score | 3 (better) | 0 |
| Growth score | 3 | 3 |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.3× (better) | 19.3× |
| P/B | 0.8× (better) | 14.6× |
| FCF yield | −252% | −1.4% (better) |
| Fair value | $7.11 | $8.51 |
| Margin of safety | 91.4% (better) | −453% |
| Growth | ||
| Revenue growth (TTM) | 12.0% | 42.8% (better) |
| Revenue growth, 5Y average | 56.4% | – |
| Profitability | ||
| Gross margin | 86.9% (better) | 80.1% |
| Operating margin | −79.5% | −37.8% (better) |
| Net margin | −84.9% | −55.8% (better) |
| FCF margin | −67.1% | −27.9% (better) |
| Return on equity | −133% | – |
| Return on invested capital | −293% | – |
| Financial health | ||
| Debt / equity | 2.94 | – |
| Interest coverage | −8.1× (better) | −23.2× |
| Current ratio | 8.04 (better) | 5.08 |
| Altman Z-score | −9.29 | 33.81 (better) |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | −2.9% | – |
| Shareholder yield | −2.9% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 57.4% | 86.0% |
| Held by insiders | 49.9% | 58.7% |
| Insider net buying, 12 months | $247K (better) | −$143M |
| Short interest, % of float | 13.6% | 15.9% |
Go deeper
- CVRX stock overview
- CVRX income statement
- CVRX valuation and score
- HTFL stock overview
- HTFL income statement
- HTFL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.